Editor Salvatore Ruggiero, DMD, MD and authors review the Diagnosis, Management and Prevention of Medication-related Osteonecrosis of the Jaw. Articles will include: Osteoporosis and bone modulation therapies: indications and outcomes; Antiresorptive therapies for the treatment of malignant osteolytic bone disease; Clinical presentation and staging of antiresorptive agent-induced osteonecrosis of the jaw; Epidemiology and risk factors of antiresorptive agent-induced osteonecrosis of the jaw; Basic science research of antiresorptive agent-induced osteonecrosis of the jaw: an update; Pathophysiology of antiresorptive agent-induced osteonecrosis of the jaw: what we know and what we don’t know; The genetics of osteonecrosis of the jaw; Preventive strategies for patients at risk of antiresorptive agent-induced osteonecrosis of the jaw; Non-operative and operative therapies for treatment of antiresorptive agent-induced osteonecrosis of the jaw; The role of anti-angiogenic therapy in the development of osteonecrosis of the jaw; Antiresorptive therapies: what they are and how do they work, and more!
1. Cover image - p. Cover 2. Title page - p. Cover 3. Table of Contents - p. Cover 4. Copyright - p. Cover 5. Contributors - p. Cover 6. Forthcoming Issues - p. Cover 7. Preface - p. Cover 8. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw - p. Cover 9. Pathophysiology of Osteonecrosis of the Jaws - p. Cover 10. Medication-Related Osteonecrosis of the Jaw: Basic and Translational Science Updates - p. Cover 11. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors - p. Cover 12. Management of Medication-Related Osteonecrosis of the Jaw - p. Cover 13. Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw - p. Cover 14. Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the Jaw - p. Cover 15. The Role of Antiangiogenic Therapy in the Development of Osteonecrosis of the Jaw - p. Cover 16. Antiresorptive Therapies for Osteoporosis - p. Cover 17. Antiresorptive Therapies for the Treatment of Malignant Osteolytic Bone Disease - p. Cover 18. Indications and Outcomes of Osteoporosis and Bone Modulation Therapies - p. Cover 19. Index - p. Cover
No hay muestra disponible
No hay ficha técnica disponible
Editor Salvatore Ruggiero, DMD, MD and authors review the Diagnosis, Management and Prevention of Medication-related Osteonecrosis of the Jaw. Articles will include: Osteoporosis and bone modulation therapies: indications and outcomes; Antiresorptive therapies for the treatment of malignant osteolytic bone disease; Clinical presentation and staging of antiresorptive agent-induced osteonecrosis of the jaw; Epidemiology and risk factors of antiresorptive agent-induced osteonecrosis of the jaw; Basic science research of antiresorptive agent-induced osteonecrosis of the jaw: an update; Pathophysiology of antiresorptive agent-induced osteonecrosis of the jaw: what we know and what we don’t know; The genetics of osteonecrosis of the jaw; Preventive strategies for patients at risk of antiresorptive agent-induced osteonecrosis of the jaw; Non-operative and operative therapies for treatment of antiresorptive agent-induced osteonecrosis of the jaw; The role of anti-angiogenic therapy in the development of osteonecrosis of the jaw; Antiresorptive therapies: what they are and how do they work, and more!
1. Cover image - p. Cover 2. Title page - p. Cover 3. Table of Contents - p. Cover 4. Copyright - p. Cover 5. Contributors - p. Cover 6. Forthcoming Issues - p. Cover 7. Preface - p. Cover 8. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw - p. Cover 9. Pathophysiology of Osteonecrosis of the Jaws - p. Cover 10. Medication-Related Osteonecrosis of the Jaw: Basic and Translational Science Updates - p. Cover 11. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors - p. Cover 12. Management of Medication-Related Osteonecrosis of the Jaw - p. Cover 13. Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw - p. Cover 14. Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the Jaw - p. Cover 15. The Role of Antiangiogenic Therapy in the Development of Osteonecrosis of the Jaw - p. Cover 16. Antiresorptive Therapies for Osteoporosis - p. Cover 17. Antiresorptive Therapies for the Treatment of Malignant Osteolytic Bone Disease - p. Cover 18. Indications and Outcomes of Osteoporosis and Bone Modulation Therapies - p. Cover 19. Index - p. Cover
No hay muestra disponible
No hay ficha técnica disponible
